Objective: Pharmacological evaluate of hydrazide, marginal analogues of naproxen, flurbiprofen and ibuprofen, well established COX inhibitors, with the goal to identifying a Cyclooxygenase (COX) inhibitor(s) with optimum potency and efficacy. The synthesized and characterized analogues were tested for their acute toxicity, anti-inflammatory, analgesic and antipyretic activities as per reported bioassay models. Molecular docking analysis was also performed to predict ligand: protein interactions.
INTRODUCTION
One of the inexhaustible areas for research is the modification of existing drug molecules, which may further be amplified, improved in potency, efficacy, or safety. Development and successful predictions of molecular computation of binding potential between the receptors (proteins) and ligands (drugs) further aided in the efforts of researchers even to design the most appropriate drug structures for both known and unknown proteins, drug discovery (1, 2).
Non-steroidal anti-inflammatory drugs (NSAIDs) is a class of drugs, which are the most widely prescribed and used medicines for their anti-inflammatory, analgesic and antipyretics activities. The selection of NSAIDs depends upon the clinical condition of patient, its Cyclooxygenase-1/2 (COX1/COX2) selectivity, duration of use, gastric ulcerative and cardiovascular risks etc., and (3) (4) (5) . Till today, a number of NSAIDs are being introduced for the treatment of acute and chronic pain, inflammation and pyrexia of different origins, belonging to different chemical classes e.g. salicylates, fenamates, propionates, acetates, oxicams etc. (6) but inflammation, despite of this tremendous advancement in the field of pharmaceutical chemistry still presents a major challenge to the researchers.
Three members of profens, arylpropionic acid class of NSAIDs, i.e. 2 (6-methoxynaphthalen-2-2yl) propanoic acid (Naproxen) (7), 2-(2-flurobiphenyl-4-yl) propanoic acid (Flurbiprofen) (8); 2-(4(2-methylproply) phenyl) propanoic acid (Ibuprofen) (9) were selected for synthesis of their marginal (hydrazide) analogues to explore their pharmacological activities along with molecular docking analysis to predict its interaction potential, being one of the acceptable tools in drug discoveries (10) . In-vivo pharmacological evaluation of the synthesised analogues with molecular docking analysis could provide a useful data for further augmentation of the existing drug molecules for optimal efficacy and safety because there is always a great need for better and safer drugs; more active, selective and thus effective drugs with lesser side or toxic effects, for cure, symptomatic treatment or prophylaxis of inflammation and its associated disorders.
MATERIAL AND METHODS

General
All chemicals, reagents, and solvents were analytical grade, purchased from commercial suppliers, and used without purification unless otherwise specified. Ibuprofen, flurbiprofen and naproxen were provided by Polyfine Chemipharma (Pvt.) Ltd, Hayatabad, Peshawar, Pakistan. Ethanol and concentrated sulfuric acid were purchased from Sigma-Aldrich, USA), Lambda Carrageenan (Sigma, USA), glacial acetic acid (Panreac, Spain), Brewer yeast (Merck, Germany) and sterile normal saline I/V (Otsuka Japan), used as received.
The purity of the products was checked on thin layer chromatographic plates of aluminum coated with silica gel (Kieselgel 60 F25, Merck, Germany), Melting points on a Bicot apparatus (Bibby Scientific Ltd UK), 1 H NMR on Bruker AV 300 and 400 MHz instruments using dimethyl sulfoxide (DMSO) as solvent, Electron impact mass spectra (EI MS) on a "JEOL MS Route" spectrometer (JMS 600-H), Infrared (IR) spectra on a "JASCO IR-A-302" spectrometer, UV spectra on Thermo Electron Vision Pro (V4.10), and C:H:N analyses were determined on a "Carlo ErbaStrumentazione" (Mod-1106) Italy.
Anti-inflammatory activity test was conducted on plethysmometer (Model LE 7500 Plan lab S.L.), anti-nociceptive activity on Hot Plate Analgesiometer (Harvard apparatus, USA) and antipyretic through digital thermometer (Model CA92121, ACON Laboratories, USA.
Statistical analysis
GraphPad Prism® (5.01) was used for statistical analysis, in vivo pharmacological activates data were analyzed by applying one-way ANOVA followed by Dunnett's post-hoc analysis.
General procedure for the synthesis of the compounds
Ibuprofen, naproxen and flurbiprofen were first converted to ethyl ester derivatives through reflux condensation with ethyl alcohol (11) . The esters thus synthesized were treated with hydrazine hydrate through reflux condensation, for 24-48 hours, in ethyl alcohol as a solvent medium (12) .
The completion of reaction was monitored through TLC, using ethyl acetate and hexane as mobile phase. The reactions were completed in 12-18 hrs. The resultant solid products (Table 1) were filtered, washed with hexane (200-400 mL) and distilled water (400-500 mL) and dried.
Pharmacology evaluation
Mice (BALB-c), either sex, were used throughout the experimental studies. Animals were 
Acute toxicity
For the toxicity study, the test compounds at the dose of 50, 100 and 500 mg/Kg body weight were administered intraperitoneally (ip) through injection to four groups having six (n=6) mice in each group. While the control group was treated with normal saline. Animal were observed for 6 hours for any behavioural changes while the mortality rates were observed at 24 hours after the administration of test compounds (13) .
Anti-inflammatory Activity Study [Carrageenan-induced paw oedema test]:
Mice were divided into five groups each containing five mice (n=6). Acute inflammation was induced by injecting 0.05 ml of (1%) carrageenan into plantar surface of mouse hind paw (14) .
Test groups I, II, and III were treated with 10, 20 and 30 mg/kg of the test compound, group-IV (control) was treated with normal saline (1 ml/kg) while the Group-V (reference standard) was with Ketoprofen (10 mg/kg), 30 min before carrageenan injection. The paw volume was measured at 0, 1, 2, 3, 4 and 5 hours using digital plethysmometer. The difference between the readings at time 0 h and different time interval was taken as the degree of oedema while was quantified as;
Where, α and β indicate, increase in paw volume of control and drug-treated animals, respectively.
Evaluation of Anti-Nociceptive Activity
Acetic acid induced writhing test in mice
Mice were divided into five groups each containing six (n=6) mice. The test groups, I, II, and III were treated with 10, 20, 30 mg/kg body weight, i.p. of the test compound, group IV (control) received normal saline (10ml/kg, i.p.) while the Group-V (reference standard) was treated with diclofenac at the dose of 10mg/ kg, i.p. After 30 minutes of the administration of the aforesaid compounds, normal saline and drug, respectively, all the five groups were treated with 0.6% acetic acid at 10ml/kg, i.p. (15) . Five minutes after acetic acid injection, mice were placed in individual cages and the numbers of writhes (abdominal contractions) were counted for each mouse for a period of 30 minutes after 5 minutes' latency period, and the percentage inhibition of writhing was calculated.
Hot plate (thermal) test in mice
Mice, of either sex, weighing 18-22 g were used in this study. As per protocol, two hours habituated animals to the laboratory environment were randomly divided into five groups, six For insertion in animal's rectum, probe of digital thermometer was lubricated with olive oil and maintained for thirty seconds for recording temperature. Those animals were selected for study that showed a minimum rise of at least 0.3-0.5°C rectal temperature.
Molecular docking simulation analysis
Molecular docking simulates the best-fit orientation of legend (drug) at the specific binding site of a receptor protein that signifies the pharmacological activity and drug designing rational with reference to that very receptor protein (18) . COX-2, due to biosynthesis of prostaglandins (PGs), is one of the key enzymes involved in inflammation. Amino acid residues at the binding site Å and a distance-dependent function of the dielectric constant were used for the calculation of the energy map. Default setting was used for other parameters. The most favorable free binding energy, after successful completion of docking, was selected as resultant ligand protein complex structure (19) . To validate the accuracy of the binding mode and binding affinity flurbiprofen was used as a reference and co-crystallized ligand (19) .
RESULTS
Acute toxicity
No acute toxicity was observed during 24 hours at doses of 50, 100, 150 mg/Kg body weight, of all the test compounds.
Anti-inflammatory activities
The anti-inflammatory activities data depicted (Figure 1 ) that TC-II in the dose of 20mg/Kg body weight have statistically significant (**p <0.005) while TC-III in all the three doses have highly significant anti-inflammatory effect (***p <0.0001) with reference to normal saline (10mL/Kg) as control and Ketoprofen 10mg/Kg, as reference standard. The doses of the three compounds were selected on the bases of average doses of the legend (drug) reported in literature.
Evaluation of anti-nociceptive activity
Hot plate (thermal) test in mice
The hot plate tests were found negative for the three test compounds the data is, therefore, not reported.
Acetic acid induced writhing test in mice
The data of anti-nociceptive activities, acetic acid induced writing test, of the test compounds (TC-I, -II & -III) with reference to normal saline 10mL/kg as control and Diclofenac 10mg/Kg as reference standard, depicted, statistically, that the results of the three test compounds were highly significant (***p<0.001) [Fig. 2 ]. The result also showed that there was a direct relation of percent pain inhibition with increase in dose of the test compounds.
Anti-pyretic evaluation study
The statistical analysis of the data of Brewer's yeast induced pyrexia test revealed that antipyretic activities of the test compounds were highly significant (*** p < 0.0001) in all the tested doses as compared to control (normal saline 10 mL/Kg) and Paracetamol reference standard (150mg/Kg body weight) [ Fig. 3 ].
Molecular docking simulations
In order to get validated and accurate binding modes and binding affinities of the test compounds, flurbiprofen was used as a reference ligand to determine its RMSD value. RMSD value of reference compound was found to be 0.49, which is a satisfactory score for validation. The analysis of the docking data revealed that the best scoring conformations of the TC-I, -II and -III were found much closer to the best scoring confirmations of flurbiprofen (Figs. 4 to 7) . All the test compounds showed considerable molecular interactions with main binding pocket of the enzyme.
The binding energy of protein-ligand interactions are given in Table 2 . (Table 2 ) and all were found considerable superimposable at anchoring site of the binding pocket (22) Figure 8 .
DISCUSSION
The opposite side of the carbonyl group of the test compounds and flurbiprofen (i.e. the second phenyl ring of TC-I and TC-II and the isobutyl group of TC-III) were oriented in a hydrophobic cleft, 2 nd anchoring site, lined with Leu352, Ser530, Val523, Try384, Phe381, Tyr385, Met522, Gly526 and Trp387, residues (22) . The entire test compounds showed good binding energies.
CONCLUSION
As the flurbiprofen has more selectivity towards COX2, its hydrazide analogue (TC-III) has shown highly significant anti-inflammatory activity in vivo followed by high binding energy / score.
While the ibuprofen and naproxen being equipotent for both COX1/COX2 and their analogues (TC-I and TC-II, respectively) have shown inhibition of both isomers in vivo. It was observed that by the addition of hydrazide group there is no change in COX2 selectivity of TC-I and -II, but their peripheral analgesic and antipyretic activities were statistically highly significant. TC-II have also shown statistically significant anti-inflammatory activity as well. The docking result revealed promising molecular interactions (docking score / energies) of the compounds in the binding pocket, especially with Arg-120 and Try-355 amino acids residue of COX2 protein, which is one Bars present as mean ± SEM of % inhibition in paw volume, for a group of five animals (n=6). 
